21 June 2006 – Case of the Week #50
These cases can also be accessed by clicking on the Case of the Week button on the left hand side of our Home Page at www.PathologyOutlines.com. This email is sent only to those who subscribe in writing or by email. To view the images or references, you must click on the links in blue.
To subscribe or unsubscribe, email info@PathologyOutlines.com, indicating subscribe or unsubscribe to Case of the Week. We do not sell, share or use your email address for any other purpose. We also maintain two other email lists: to receive a biweekly update of new jobs added to our Jobs page, and to receive a monthly update of changes made to the website. You must subscribe or unsubscribe separately to these email lists.
This Case is sponsored by Sakura Finetek, USA. Leading the revolution in Pathology, the Tissue-Tek® Xpress® Rapid Tissue Processor is helping laboratories achieve new levels of productivity. Enabling a continuous flow of up to 40 cassettes every 15 minutes, this system can process up to 120 specimens per hour. The Xpress® allows for a balanced distribution of work throughout the day, eliminating bottlenecks and batches common with overnight processing. Improved turnaround times, reduced waste, and increased productivity are just a few benefits this technology can offer your lab. Results are the same or better than overnight processing. Help your lab reach its full potential with the Tissue-Tek® Xpress® Rapid Tissue Processor. For more information, contact Ms. Elise Green, Marketing Manager at 1-800-725-8723 extension 7873 or at firstname.lastname@example.org
We thank Dr. Victor Lee, KK Women’s and Children’s Hospital, Singapore, for contributing this case. We invite you to contribute a Case of the Week by sending an email to NPernick@PathologyOutlines.com with microscopic images (any size, we will shrink if necessary) in JPG or GIF format, a short clinical history, your diagnosis and any other images (gross, immunostains, EM, etc.) that may be helpful or interesting. We will write the discussion (unless you want to), list you as the contributor, and send you a check for $35 (US) for your time after we send out the case. Please only send cases with a definitive diagnosis.
Case of the Week #50
A 12 year old girl had a solitary superficial tumor of the back. She had no significant medical history.
What is your diagnosis?
(scroll down to continue)
Plexiform schwannoma (superficial type)
The microscopic images show a plexiform architecture (image1), with nuclear palisading identifiable at medium power (image2). Although schwannomas usually have a biphasic pattern of Antoni A (short fascicles of spindle cells with nuclear palisading and Verocay bodies) and Antoni B areas (less cellular areas with irregularly spaced vessels), it is not prominent in these images. There are also more cellular areas (image3), and strong S100 immunoreactivity.
Only 5% of schwannomas have a plexiform or multinodular growth pattern. Unlike neurofibromas, this pattern is not strongly associated with neurofibromatosis 1 or 2. These tumors usually are superficial, and located in the dermis or subcutaneous tissue. They are frequently cellular with hyperchromatic nuclei and increased mitotic figures. There is usually no/minimal necrosis or myxoid change. All tumors show strong and diffuse S100 immunoreactivity of the nodules, with no staining of the intervening stroma.
The differential diagnosis includes plexiform neurofibroma and malignant peripheral nerve sheath tumor (MPNST). Plexiform neurofibromas almost always develop during early childhood and are considered pathognomonic for neurofibromatosis type 1. They are associated with grossly enlarged and tortuous nerves. Microscopically, they are hypocellular with a myxoid background and lack the biphasic pattern seen in schwannomas. However, they occasionally show nuclear palisading. Although neurofibromas are S100 immunoreactive, there is only staining of scattered cells that are diffusely throughout the lesion. In contrast, schwannomas show strong staining of the tumor nodules and no staining of the intervening stroma.
The cellularity, mitotic activity and atypia of plexiform schwannomas is also suggestive of MPNST, which may be multinodular, particularly if it arises from a plexiform neurofibroma. Before diagnosing a plexiform MPNST, it is recommended to sample the tumor extensively to rule out a plexiform schwannoma (Am J Surg Path 2005;29:1042). S100 staining may be somewhat helpful, as MPNSTs typically show negative or weak staining.
Additional references: Weiss: Enzinger and Weiss’s Soft Tissue Tumors 2001 (4th ed)
Nat Pernick, M.D.
30100 Telegraph Road, Suite 404
Bingham Farms, Michigan (USA) 48025